Targeting UCH in Drosophila melanogaster as a model for Parkinson's disease

被引:4
|
作者
Dang Thi Phuong Thao [1 ]
机构
[1] Univ Sci, Lab Mol Biotechnol, VNU HCM, 227 Nguyen Van Cu St,Dist 5, Ho Chi Minh City, Vietnam
来源
关键词
Fly PD model; Parkinson disease; PD-like symptoms; Drug screening; Review; UBIQUITIN HYDROLASE UCHL1; ACTIVE-SITE; NEURONS; BINDING; BRAIN;
D O I
10.2741/4800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disease caused by genetic or environmental factors. Among several animal models, the Drosophila melanogaster is one of the valuable models widely used in studying genes and proteins implicated in PD. UCH-L1 (Ubiquitin carboxyl-terminal hydrolase L1) which is involved in formation of Lewy bodies, shows loss of function mutations in PD causing degeneration of dopaminergic neurons in mice. Here, we summarize the results from studying the UCH-L1 and its knockdown in Drosophila model of PD with respect to movement, degeneration of dopamine producing neurons, dopamine deficiency and age dependent dependency of progression of the disease. The knockdown of the UCH-L1 in Drosophila can be used in studying the epidemiology of the disease as well as in drug screening for finding therapeutic targets for PD.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 50 条
  • [1] Drosophila melanogaster a Versatile Model of Parkinson's Disease
    Naz, Falaq
    Siddique, Yasir Hasan
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (06) : 487 - 530
  • [2] Disease model organism for Parkinson disease: Drosophila melanogaster
    Aryal, Binod
    Lee, Youngseok
    [J]. BMB REPORTS, 2019, 52 (04) : 250 - 258
  • [3] The neuroprotective effect of fullerenols on a model of Parkinson's disease in Drosophila melanogaster
    Golomidov, I
    Bolshakova, O.
    Komissarov, A.
    Sharoyko, V
    Slepneva, E.
    Slobodina, A.
    Latypova, E.
    Zherebyateva, O.
    Tennikova, T.
    Sarantseva, S.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 523 (02) : 446 - 451
  • [4] A new metabolic model of Drosophila melanogaster and the integrative analysis of Parkinson's disease
    Cesur, Mueberra Fatma
    Basile, Arianna
    Patil, Kiran Raosaheb
    Cakir, Tunahan
    [J]. LIFE SCIENCE ALLIANCE, 2023, 6 (08)
  • [5] Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster
    Pendleton, RG
    Parvez, F
    Sayed, M
    Hillman, R
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (01): : 91 - 96
  • [6] Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson's Disease
    Mannett, Brady T.
    Capt, Braden C.
    Pearman, Krista
    Buhlman, Lori M.
    VandenBrooks, John M.
    Call, Gerald B.
    [J]. PARKINSONS DISEASE, 2022, 2022
  • [7] Effects of pharmacological agents upon a transgenic model of Parkinson's Disease in Drosophila melanogaster
    Pendleton, RG
    Parvez, F
    Sayed, M
    Hillman, R
    [J]. FASEB JOURNAL, 2002, 16 (04): : A567 - A567
  • [8] Effect of cabergoline alginate nanocomposite on the transgenic Drosophila melanogaster model of Parkinson's disease
    Khanam, Saba
    Naz, Falaq
    Ali, Fahad
    Jyoti, Rahul Smita
    Fatima, Ambreen
    Khan, Wasi
    Singh, Braj Raj
    Naqvi, A. H.
    Siddique, Yasir Hasan
    [J]. TOXICOLOGY MECHANISMS AND METHODS, 2018, 28 (09) : 699 - 708
  • [9] Models of Parkinson's Disease with Special Emphasis on Drosophila melanogaster
    Fatima, Ambreen
    Jyoti, Smita
    Siddique, Yasir Hasan
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (10) : 757 - 766
  • [10] A Drosophila model of Parkinson's disease
    Feany, MB
    Bender, WW
    [J]. NATURE, 2000, 404 (6776) : 394 - 398